<DOC>
	<DOCNO>NCT01743027</DOCNO>
	<brief_summary>The purpose study evaluate ophthalmic solution treatment ocular itching associate allergic conjunctivitis use Conjunctival Allergen Challenge ( CAC ) model .</brief_summary>
	<brief_title>Efficacy Safety Ophthalmic Solution Patients With Allergic Conjunctivitis</brief_title>
	<detailed_description>Enrolled participant test presence common allergy use Conjunctival Allergen Challenge ( CAC ) model . Drops increase concentration solubilized allergen instilled eye positive reaction occur . The test repeat confirm allergic reaction . Participants confirm reaction administer test article ( Day 0 ) undergo CAC 24 hour post-instillation ( Day 1 ) . On Day 14 , participant administer test article undergo additional CAC .</detailed_description>
	<mesh_term>Conjunctivitis</mesh_term>
	<mesh_term>Conjunctivitis , Allergic</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Olopatadine Hydrochloride</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<criteria>Able dosed eye , able willing make require study visit follow instruction . Negative urine pregnancy test female childbearing potential use adequate birth control throughout study period . Diagnostic skin test indicative allergy cat hair , cat dander , grass , ragweed , dust mite , dog dander , cockroach and/or tree within 24 month prior Visit 1 Visit 1 . History seasonal perennial allergic conjunctivitis least 1 year prior Visit 1 . Bestcorrected visual acuity 55 great eye measure ETDRS ( letter read method ) . Manifest positive bilateral Conjunctival Allergen Challenge ( CAC ) test response . Willing discontinue contact lens wear least 72 hour prior Visit 1 throughout study . Other protocoldefined inclusion criterion may apply . Known history presence persistent dry eye syndrome , currently require frequent use artificial tear , gel lubricant , presence punctal plug , use RestasisÂ® , topical ocular corticosteroid dryness eye . Presence ocular condition may affect study outcome . History evidence ocular surgery ( include refractive procedure LASIK , PRK RK ) within 6 month Visit 1 . Presence signs/symptoms active allergic conjunctivitis start Visits 1 , 2 , 3A , 4 . History anaphylactic reaction allergen use study . Current evidence recent ( within 6 month ) history severe , unstable , uncontrolled medical condition and/or relevant systemic disease . Use disallow medication without protocolspecified washout period prior Visit 1 , study . Other protocoldefined exclusion criterion may apply .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2014</verification_date>
	<keyword>Allergic conjunctivitis</keyword>
	<keyword>Olopatadine HCl solution</keyword>
	<keyword>Conjunctival Allergen Challenge</keyword>
	<keyword>Itching eye</keyword>
	<keyword>Ocular allergy</keyword>
	<keyword>PATADAY</keyword>
	<keyword>PATANOL</keyword>
</DOC>